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Abstract: A critical shortage of donor organs for treating end-stage
organ failure highlights the urgent need for generating organs from
human induced pluripotent stem cells (iPSCs). Despite many reports
describing functional cell differentiation, no studies have succeeded
in generating a three-dimensional vascularized organ such as liver.
Here we show the generation of vascularized and functional human
liver from human iPSCs by transplantation of liver buds created
in vitro (iPSC-LBs). Speciﬁed hepatic cells (immature endodermal
cells destined to track the hepatic cell fate) self-organized into
three-dimensional iPSC-LBs by recapitulating organogenetic interac-
tions between endothelial and mesenchymal cells. Immunostaining
and gene-expression analyses revealed a resemblance between
in vitro grown iPSC-LBs and in vivo liver buds. Human vasculatures
in iPSC-LB transplants became functional by connecting to the host
vessels within 48 hours. The formation of functional vasculatures
stimulated the maturation of iPSC-LBs into tissue resembling the
adult liver. Highly metabolic iPSC-derived tissue performed liver-
speciﬁc functions such as protein production and human-speciﬁc
drug metabolism without recipient liver replacement. Furthermore,
mesenteric transplantation of iPSC-LBs rescued the drug-induced
lethal liver failure model. To our knowledge, this is the ﬁrst report
demonstrating the generation of a functional human organ from
pluripotent stem cells. Although efforts must ensue to translate these
techniques to treatments for patients, this proof-of-concept demon-
stration of organ-bud transplantation provides a promising new
approach to study regenerative medicine.
 2013 European Association for the Study of the Liver. Published
by Elsevier B.V.
Despite agreement that portal injections of mature hepatocytes
are partially effective in patients with hereditary metabolic liver
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E-mail address: dominique.franco@abc.aphp.fr.diseases [1], the goal of replacing liver transplantation with this
technique remains far off. Low functioning hepatocyte availabil-
ity, a 50% cell loss during the procedure and difﬁculties in getting
transplanted hepatocytes to integrate into liver plates and prolif-
erate are the main causes of failure. The injection of stem cells
rather than mature hepatocytes has given interesting results in
speciﬁc rodent models [2], but there have been few trials in
humans. Strategies for replacing liver transplantation have
recently focused on the in vitro construction of bio-engineered
livers. Decellularization-recellularization techniques have
yielded liver-like transplantable organoids in small animals
[3,4]. Much remains to be done, particularly concerning the cells
used for repopulation, before this complex procedure can be
applied to humans.
Until recently, it was generally believed that liver organogen-
esis could not be reproduced in vitro, for the construction of a
new liver de novo. In this study, Takabe and coworkers from
Yokohama City University were able to construct a liver in a Petri
dish, by culturing hepatic endoderm cells derived from human
iPSCs (iPSC-HEs) with human umbilical vein endothelial cells
(HUVECs) and human mesenchymal stem cells (MSCs). The cells
were plated in two-dimensional conditions, but the human iPSC-
HEs self-organized into macroscopically visible, mechanically
stable, manipulable, three-dimensional cell clusters — iPSC-
derived liver buds (iPSC-LBs) — four to eight days after seeding.
In vitro, cells in human iPSC-LBs expressed early hepatic marker
genes and were more functional than the hepatocyte-like cells
generated from hiPSCs according to conventional procedures
[5,6]. The FGF and BMP pathways, which play key roles in organ-
ogenesis, were upregulated when iPSC-HEs were co-cultured
with HUVECs and MSCs. The entire process in the Petri dish clo-
sely resembled the development in vivo of liver buds from the
foregut in human and mouse embryos. Human iPSC-LBs were
transplanted into ectopic sites in immunodeﬁcient mice, in which
they grew and divided. Using the cranial window model, the
authors observed the development of a human vasculature
within the iPSC-LBs. Human blood vessels within the transplant
became patent by connecting to the vessels of the mouse host
at the edge of the transplant within 48 h of transplantation,
resulting in a vascularized organoid. Two months later, the orga-
noid had a vascular network, including sinusoids and hepatic
cord organization with tight junctions. Most of the cells in the
transplanted iPSC-LBs had developed into fully mature hepato-
cytes, with only a small percentage retaining fetal characteristics.
Metabolic studies in mice with cranial windows or capsular
iPSC-LB transplants, with drugs metabolized by different path-
ways in mice and humans, conﬁrmed the appropriate functioning
of transplanted human liver buds. Albumin production by14 vol. 60 j 455–456
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Fig. 1. General scheme of the experiments.
International HepatologyhiPSC-LBs increased over time and was clearly stronger than that
of human adult hepatocytes transplanted to the same sites. The
functionality of a mesenteric transplant of hiPSC-LBs was further
investigated in two models of acute liver failure in mice. In both
models, hiPSC-LB transplantation signiﬁcantly increased survival
(Fig. 1).
This constitutes a major breakthrough in the production of
bioengineered livers. For the ﬁrst time, a tiny, rudimentary liver
has been generated from a few cells in a Petri dish, and the trans-
plantation of this organoid ultimately protected mice against
acute liver failure. The use of stromal cells to coax iPS-HEs into
appropriate differentiation appears to be the key to obtaining
the correct three-dimensional organization, maturation of cells
and vascularization. Of course, much remains to be done to
improve bud quality before this technique could be applied in
clinical practice. For example, the ultrastructural organization
of the bud does not entirely reﬂect the lobular organization of a
normal liver. There is also no development of an external bile
tree, potentially resulting in the accumulation of bile acids, which
might jeopardize the long-term functioning of the transplanted
bud. It also remains unclear whether similar results could be
obtained in larger animals. Above all, such buds cannot be trans-
planted orthotopically. The best indication might, therefore, be
the treatment of hereditary metabolic liver diseases, in which
the host liver can be left in place and a genetically corrected
bud implanted in the mesentery [7]. Buds could also be used as
a bridging technique in patients with cirrhosis on the waiting list
for transplantation, but bud generation may take too long for use
in patients with acute liver failure. In addition to potential clinical
applications, this study provides important information about the
types of cells most suitable for liver construction, which could be
applied to the recellularization of scaffolds. This technique may
also prove a formidable tool for pharmacological studies. It is just456 Journal of Hepatology 201one of many new technologies emerging in medical sciences. A
mixture of these techniques, undoubtedly including layer-by-
layer 3D printing [8], will probably ultimately be required for
the de novo bioengineering of livers.
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